UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Activation of nuclear factor-κ B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients

Endocrine-related cancer, 2006-06, Vol.13 (2), p.607-616

2006

Volltextzugriff (PDF)

Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer

Annals of oncology, 2007-08, Vol.18 (8), p.1359-1362

2007

Volltextzugriff (PDF)

Vegetable and fruit intake and the risk of lung cancer in women in Barcelona, Spain

European journal of cancer (1990), 1997-07, Vol.33 (8), p.1256-1261

1997

Volltextzugriff (PDF)

Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis

European journal of cancer (1990), 1998-01, Vol.34 (1), p.193-195

1998

Volltextzugriff (PDF)

Decreased survival of patients with lung cancer admitted to a teaching hospital through the emergency department in Barcelona, Spain

Journal of epidemiology and community health (1979), 1998-02, Vol.52 (2), p.137-138

1998

Volltextzugriff (PDF)

Phase II study of capecitabine (X) + docetaxel (T) as neoadjuvant treatment in patients (pts) with locally advanced breast cancer (LABC) including biological correlates

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.664-664

2006

Volltextzugriff (PDF)

Phase II trial of temozolomide as first-line treatment for patients with advanced gynecological sarcoma: A Spanish Group for Research on Sarcomas (GEIS) and Spanish Ovarian Cancer Research Group (GEICO) study

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.9570-9570

2006

Volltextzugriff (PDF)

Phase II study of capecitabine (C) in combination with docetaxel (D) as neoadjuvant treatment in patients with locally advanced breast cancer (IIIA and IIIB stage)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.752-752

2004

Volltextzugriff (PDF)

Phase II study of capecitabine (C) in combination with docetaxel (D) as neoadjuvant treatment in patients with locally advanced breast cancer (IIIA and IIIB stage)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.752-752

2004

Volltextzugriff (PDF)

Phase II study of capecitabine (C) in combination with docetaxel (D) as neoadjuvant treatment in patients with locally advanced breast cancer (IIIA and IIIB stage). Correlation between clinico-pathological response and fluoropyrimidine-enzyme profile. Early results

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.735-735

2005

Volltextzugriff (PDF)

Prolonged infusion of gemcitabine in patients with platinum resistant or refractory recurrent ovarian carcinoma: A phase II study Of GEICO (Spanish Group for investigation on ovarian cancer)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.5101-5101

2005

Volltextzugriff (PDF)

A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2000-05, Vol.28 (2), p.109-115

2000

Volltextzugriff (PDF)

Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4544-4544

2004

Volltextzugriff (PDF)

Expression of cyclooxygenase-2 mRNA (COX2-mRNA) in peripheral blood (PB) of head and neck cancer patients (HNC) and healthy controls (HC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.5521-5521

2004

Volltextzugriff (PDF)

Expression of cyclooxygenase-2 mRNA (COX2-mRNA) in peripheral blood (PB) of head and neck cancer patients (HNC) and healthy controls (HC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.5521-5521

2004

Volltextzugriff (PDF)

Phase II Study of Estramustine and Vinorelbine in Hormone-Refractory Prostate Carcinoma Patients

Acta oncologica, 1998, Vol.37 (2), p.187-191

Joan Carles, Montserrat Domenech, Antonio Gelabert-Mas, Miquel Nogue, Josep M. Tabernero, Angeles Arcusa, Inmaculada Guasch, Ana Miguel, Juan J. Ballesteros, Xavier Fabregat

1998

Volltextzugriff (PDF)

Survival analysis of a serie of 100 patients with locally advanced unresectable non-small cell lung cancer (NSCLC) treated with a sequential schedule of cisplatin-based chemotherapy (CBC) and radiotherapy (RDT)

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.117-117

2000

Volltextzugriff (PDF)

Lung cancer and cigarette smoking in women: A case‐control study in barcelona (Spain)

International journal of cancer, 1994-10, Vol.59 (2), p.165-169

1994

Volltextzugriff (PDF)

Sequential methotrexate, 5‐fluorouracil (5‐FU), and high dose leucovorin versus 5‐FU and high dose leucovorin versus 5‐FU alone for advanced colorectal cancer. A multi‐institutional randomized trial

Cancer, 1995-03, Vol.75 (6), p.1238-1244

1995

Volltextzugriff (PDF)

215 Gemcitabine, ifosfamide and cisplatin (GIP) in the treatment of advanced non-small cell lung cancer. A phase II trial

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.56-56

1997

Volltextzugriff (PDF)

Fibrolamellar Hepatic Tumor with Neurosecretory Features and Systemic Deposition of AA Amyloid

Ultrastructural pathology, 1994, Vol.18 (1-2), p.287-292

1994

Volltextzugriff (PDF)

349 Sequential chemotherapy and radiotherapy in the treatment of inoperable stage III A-B non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.89-89

1997

Volltextzugriff (PDF)

Phase II study of mitonafide in advanced and relapsed colorectal cancer

Investigational new drugs, 1996-01, Vol.14 (2), p.223-225

1996

Volltextzugriff (PDF)

Anal carcinoma: a 14 year experience

Revista española de enfermedades digestivas, 1997-01, Vol.89 (1), p.23

1997

Volltextzugriff (PDF)

Three arms randomized trial comparing methoirexaie, 5-FU and leucovorin (MFL) vs 5-FU, leucovorin (FL) vs 5-FU (F) in advanced and meiasiatic colorectal cancer. (final results)

European journal of cancer (1990), 1993, Vol.29, p.S89-S89

1993

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(89)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(45)
Science & Technology
(39)
Female
(34)
Middle Aged
(33)
Life Sciences & Biomedicine
(32)
Male
(32)
Aged
(29)
Adult
(24)
Biological And Medical Sciences
(18)
Medical Sciences
(17)
Surgery
(11)
Transplantation
(11)
Oncology
(10)
Prognosis
(10)
Prospective Studies
(8)
Risk Factors
(8)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(8)
Aged, 80 And Over
(7)
Follow-Up Studies
(7)
Immunology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activation of nuclear factor-κ B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients

Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer

Vegetable and fruit intake and the risk of lung cancer in women in Barcelona, Spain

Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis

Decreased survival of patients with lung cancer admitted to a teaching hospital through the emergency department in Barcelona, Spain

Phase II study of capecitabine (X) + docetaxel (T) as neoadjuvant treatment in patients (pts) with locally advanced breast cancer (LABC) including biological correlates

Phase II trial of temozolomide as first-line treatment for patients with advanced gynecological sarcoma: A Spanish Group for Research on Sarcomas (GEIS) and Spanish Ovarian Cancer Research Group (GEICO) study

Phase II study of capecitabine (C) in combination with docetaxel (D) as neoadjuvant treatment in patients with locally advanced breast cancer (IIIA and IIIB stage)

Phase II study of capecitabine (C) in combination with docetaxel (D) as neoadjuvant treatment in patients with locally advanced breast cancer (IIIA and IIIB stage)

Phase II study of capecitabine (C) in combination with docetaxel (D) as neoadjuvant treatment in patients with locally advanced breast cancer (IIIA and IIIB stage). Correlation between clinico-pathological response and fluoropyrimidine-enzyme profile. Early results

Prolonged infusion of gemcitabine in patients with platinum resistant or refractory recurrent ovarian carcinoma: A phase II study Of GEICO (Spanish Group for investigation on ovarian cancer)

A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer

Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer

Expression of cyclooxygenase-2 mRNA (COX2-mRNA) in peripheral blood (PB) of head and neck cancer patients (HNC) and healthy controls (HC)

Expression of cyclooxygenase-2 mRNA (COX2-mRNA) in peripheral blood (PB) of head and neck cancer patients (HNC) and healthy controls (HC)

Phase II Study of Estramustine and Vinorelbine in Hormone-Refractory Prostate Carcinoma Patients

Survival analysis of a serie of 100 patients with locally advanced unresectable non-small cell lung cancer (NSCLC) treated with a sequential schedule of cisplatin-based chemotherapy (CBC) and radiotherapy (RDT)

Lung cancer and cigarette smoking in women: A case‐control study in barcelona (Spain)

Sequential methotrexate, 5‐fluorouracil (5‐FU), and high dose leucovorin versus 5‐FU and high dose leucovorin versus 5‐FU alone for advanced colorectal cancer. A multi‐institutional randomized trial

215 Gemcitabine, ifosfamide and cisplatin (GIP) in the treatment of advanced non-small cell lung cancer. A phase II trial

Fibrolamellar Hepatic Tumor with Neurosecretory Features and Systemic Deposition of AA Amyloid

349 Sequential chemotherapy and radiotherapy in the treatment of inoperable stage III A-B non-small cell lung cancer (NSCLC)

Phase II study of mitonafide in advanced and relapsed colorectal cancer

Anal carcinoma: a 14 year experience

Three arms randomized trial comparing methoirexaie, 5-FU and leucovorin (MFL) vs 5-FU, leucovorin (FL) vs 5-FU (F) in advanced and meiasiatic colorectal cancer. (final results)

Suchergebnisse filtern